HLA-DR-mediated signals for hematopoiesis and induction of apoptosis involve but are not limited to a nitric oxide pathway

Blood

Volumn 90, Issue 1, 1997, Pages 217-225

  Lee, Jong Wook ^a   Beckham, Cassandra ^a   Michel, Bryce R ^a   Rosen, Henry ^a   Deeg, H Joachim ^a,b  

^a UNIVERSITY OF WASHINGTON   (United States)

^b Fred Hutchinson Cancer Research Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCYSTEINE; ANTIOXIDANT; HLA DR ANTIGEN; LINSIDOMINE; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MONOCLONAL ANTIBODY; N(G) METHYLARGININE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE INHIBITOR;

ANIMAL CELL; APOPTOSIS; ARTICLE; COLONY FORMING UNIT GM; CONTROLLED STUDY; DOG; HEMATOPOIESIS; HUMAN; HUMAN CELL; MACROPHAGE; MONOCYTE; MONONUCLEAR CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

EID: 0040550693     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v90.1.217     Document Type: Article

References (46)

1. Nathan CF, Hibbs JB Jr: Role of nitric oxide synthesis in macrophage antimicrobial activity. Curr Opin Immunol 3:65, 1991
2. Garthwaite J, Charles SL, Chess-Williams R: Endothelium-derived relaxing factor release on activation of NMDA receptors suggests role as intercellular messenger in the brain. Nature 336:385, 1988
3. Aisaka K, Gross SS, Griffith OW, Levi R: NG-methylarginine, an inhibitor of endothelium-derived nitric oxide synthesis, is a potent pressor agent in the guinea pig: Does nitric oxide regulate blood pressure in vivo? Biochem Biophys Res Comm 160:881, 1989
4. Nathan CF: Nitric oxide as a secretory product of mammalian cells. FASEB J 6:3051, 1992
5. Moncada S, Palmer RMJ, Higgs EA: Nitric oxide: Physiology, pathophysiology and pharmacology. Pharmacol Rev 43:109, 1991
6. Ding AH, Nathan CF, Stuehr DJ: Release of reactive nitrogen intermediates and reactive oxygen intermediates from mouse peritoneal macrophages. Comparison of activating cytokines and evidence for independent production. J Immunol 141:2407, 1988
7. Nussler AK, Di Silvio M, Billiar TR, Hoffman RA, Geller DA, Selby R, Madariaga J, Simmons RL: Stimulation of the nitric oxide synthase pathway in human hepatocytes by cytokines and endotoxin. J Exp Med 176:261, 1992
8. Kilbourn RG, Belloni P: Endothelial cell production of nitrogen oxides in response to interferon gamma in combination with tumor necrosis factor, interleukin-1, or endotoxin. J Natl Cancer Inst 82:772, 1990
9. Drapier JC, Wietzerbin J, Hibbs JB Jr: Interferon-gamma and tumor necrosis factor induce the L-arginine-dependent cytotoxic effector mechanism in murine macrophages. Eur J Immunol 18:1587, 1988
10. Hibbs JB Jr, Westenfelder C, Taintor R, Vavrin Z, Kablitz C, Baranowski RL, Ward JH, Menlove RL, McMurry MP, Kushner JP, Samlowski WE: Evidence for cytokine-inducible nitric oxide synthesis from L-arginine in patients receiving interleukin-2 therapy. J Clin Invest 89:867, 1992
11. Maciejewski JP, Selleri C, Sato T, Cho HJ, Keefer LK, Nathan CF, Young NS: Nitric oxide suppression of human hematopoiesis in vitro. Contribution to inhibitory action of interferon-gamma and tumor necrosis factor-alpha. J Clin Invest 96:1085, 1995
12. Mannick JB, Asano K, Izumi K, Kieff E, Stamler JS: Nitric oxide produced by human B lymphocytes inhibits apoptosis and Epstein-Barr virus reactivation. Cell 79:1137, 1994
13. Kaneto H, Fujii J, Seo HG, Suzuki K, Matsuoka T, Nakamura M, Tatsumi H, Yamasaki Y, Kamada T, Taniguchi N: Apoptotic cell death triggered by nitric oxide in pancreatic beta-cells. Diabetes 44:733, 1995
14. Sicher SC, Chung GW, Vazquez MA, Lu CY: Augmentation or inhibition of IFN-γ-induced MHC class II expression by lipopolysaccharides - The roles of TNF-α and nitric oxide, and the importance of the sequence of signaling. J Immunol 155:5826, 1995
15. Punjabi CJ, Laskin DL, Heck DE, Laskin JD: Production of nitric oxide by murine bone marrow cells: inverse correlation with cellular proliferation. J Immunol 149:2179, 1992
16. + human bone marrow cells. Blood 87:977, 1996
17. Shami PJ, Moore JO, Gockerman JP, Hathorn JW, Misukonis MA, Weinberg JB: Nitric oxide modulation of the growth and differentiation of freshly isolated acute non-lymphocytic leukemia cells. Leuk Res 19:527, 1995
18. Albina JE, Cui S, Mateo RB, Reichner JS: Nitric oxide-mediated apoptosis in murine peritoneal macrophages. J Immunol 150:5080, 1993
19. Buttke TM, Sandstrom PA: Oxidative stress as a mediator of apoptosis. Immunol Today 15:7, 1994
20. Greinix HT, Ladiges WC, Graham TC, Maslan S, Raff RF, Sandmaier BM, Appelbaum FR, Schuening FG, Deeg HJ, Storb R: Late failure of autologous marrow grafts in lethally irradiated dogs given anti-class-II monoclonal antibody. Blood 78:2131, 1991
21. Deeg HJ, Beckham C, Huss R, Myerson D, Greinix H, Appelbaum FR, Graham T, Schuening F, Storb R: Rescue from anti-MHC class II antibody-mediated marrow graft failure by c-Kit ligand. Blood 83:2352, 1994
22. Hong D-S, Beckham C, Huss R, Lee JW, Hockenbery D, Ledbetter JA, Deeg HJ: MHC class II mediated inhibition of hemopoiesis in long-term marrow cultures involves apoptosis and is prevented by C-kit ligand. Blood 86:3341, 1995
23. Hauschildt S, Bessler WG, Scheipers P: Engagement of major histocompatibility complex class II molecules leads to nitrite production in bone marrow-derived macrophages. Eur J Immunol 23:2988, 1993
24. Ladiges WC, Storb R, Thomas ED: Canine models of bone marrow transplantation. Lab Anim Sci 40:11, 1990
25. Greinix HT, Storb R, Bartelmez SH: Specific growth inhibition of primitive hematopoietic progenitor cells mediated through monoclonal antibody binding to major histocompatibility class II molecules. Blood 80:1950, 1992
26. Edelson PJ, Cohn ZA: Purification and cultivation of monocytes and macrophages, in Bloom BA, David JR (eds): In Vitro Methods in Cell-Mediated and Tumor Immunity, San Diego, CA, Academic, 1976, p 333
27. Accolla RS, Birnbaum D, Pierres M: The importance of cross-reactions between species: Mouse allo-anti-Ia monoclonal antibodies as a powerful tool to define human Ia subsets. Hum Immunol 8:75, 1983
28. Ladiges WC, Pesando JM, Severns E, Longton G, Deeg HJ, Storb R: Selective inhibition of the canine mixed lymphocyte response by HLA-DR and DP-reactive monoclonal antibodies. Transplantation 45:484, 1988
29. Schuening FG, Storb R, Meyer J, Goehle S: Long-term culture of canine bone marrow cells. Exp Hematol 17:411, 1989
30. Dexter TM, Allen TD, Lajtha LG: Conditions controlling the proliferation of haemopoietic stem cells in vitro. J Cell Physiol 91:335, 1977
31. Srour EF, Brandt JE, Briddell RA, Grigsby S, Leemhuis T, Hoffman R: Long-term generation and expansion of human primitive hematopoietic progenitor cells in vitro. Blood 81:661, 1993
32. Fried J, Perez AG, Clarkson BD: Rapid hypotonic method for flow cytofluorometry of monolayer cell cultures. Some pitfalls in staining and data analysis. J Histochem Cytochem 26:921, 1978
33. Nicoletti I, Migliorati G, Pagliacci MC, Grignani F, Riccardi C: A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry. J Immunol Methods 139:271, 1991
34. Drobyski WR, Keever CA, Hanson GA, McAuliffe T, Griffith OW: Inhibition of nitric oxide production is associated with enhanced weight loss, decreased survival, and impaired alloengraftment in mice undergoing graft-versus-host disease after bone marrow transplantation. Blood 84:2363, 1994
35. Maciejewski J, Selleri C, Anderson S, Young NS: Fas antigen expression on CD34+ human marrow cells is induced by interferon gamma and tumor necrosis factor alpha and potentiates cytokine-mediated hematopoietic suppression in vitro. Blood 85:3183, 1995
36. Lee JW, Beckham C, Gersuk G, Kiener P, Deeg HJ: HLA-DR-initiated inhibition of hematopoiesis involves apoptosis via a Fas/Fas-ligand pathway. Exp Hematol 24:1084, 1996 (abstr)
37. Yim CY, Hibbs JB Jr, McGregor JR, Galinsky RE, Samlowski WE: Use of N-acetyl cysteine to increase intracellular glutathione during the induction of antitumor responses by IL-2. J Immunol 152:5796, 1994
38. Dröge W, Schulze-Osthoff K, Mihm S, Galter D, Schenk H, Eck HP, Roth S, Gmunder H: Functions of glutathione and glutathione disulfide in immunology and immunopathology. FASEB J 8:1131, 1994
39. Sandstrom PA, Mannie MD, Buttke TM: Inhibition of activation-induced death in T cell hybridomas by thiol antioxidants: Oxidative stress as a mediator of apoptosis. J Leuk Biol 55:221, 1994
40. Adler H, Adler B, Peveri P, Werner ER, Wachter H, Peterhans E, Junji TW: Differential regulation of inducible nitric oxide synthase production in bovine and caprine macrophages. J Infect Dis 173:971, 1996
41. Lee JW, Michel BR, Beckham C, Rosen H, Deeg HJ: Nitric oxide (NO) and MHC class II mediated signals as regulators of hematopoiesis. Blood 86:670a, 1995 (abstr. suppl 1)
42. Schneemann M, Schoedon G, Hofer S, Blau N, Guerrero L, Schaffner A: Nitric oxide synthase is not a constituent of the antimicrobial armature of human mononuclear phagocytes. J Infect Dis 167:1358, 1993
43. Nicholson S, Bonecini-Almeida M da G, Lapae Silva JR, Nathan C, Xie QW, Mumford R, Weidner JR, Calaycay J, Geng J, Boechat N, Linhares C, Rom W, Ho JL: Inducible nitric oxide synthase in pulmonary alveolar macrophages from patients with tuberculosis. J Exp Med 183:2293, 1996
44. Yamaguchi M, Gersuk G, Nadler S, Deeg HJ: HLA-DR mediated apoptosis and inhibition of hematopoiesis involves upregulation of tumor necrosis factor alpha. Exp Hematol 24:1100, 1996 (abstr)
45. KB transcription factor and HIV-1. EMBO J 10:2247, 1991
46. Trede NS, Geha RS, Chatila T: Transcriptional activation of IL-1 beta and tumor necrosis factor-alpha genes by MHC class II ligands. J Immunol 146:2310, 1991